Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734

First up, Jason breaks down Uber’s huge Q1 results! (1:21) Then, Unlearn.AI CEO Charles Fisher joins to discuss the advancements his company is making in fast-tracking clinical trials (9:49), how machine learning is used in drug development (16:24), Unlearn’s business model (35:24), and more! (0:00) Jason kicks off the show (1:21) Uber’s Q1 earnings  (8:31) QuickNode - Get one month free by using code TWIST at https://go.quicknode.com/twist (9:49) The foundation of Unlearn.AI (12:42) Unlearn.AI’s impact on the clinical trial process (14:24) Criticisms of the current clinical trial model (16:24) ML’s Impact on drug discovery  (24:16) CacheFly - Get 10 terabytes free by signing up at https://twist.cachefly.com (25:42) The data used in the medical system today (34:05) Microsoft for Startups Founders Hub - Apply in 5 minutes for six figures in discounts at http://aka.ms/thisweekinstartups (35:24) Unlearn.AI’s business model (40:22) Building a foundational model for health (44:06) The pace of AI today vs. the previous decade (46:35) More on Unlearn.AI’s business model (48:15) Creating foundational datasets in health FOLLOW Charles: https://twitter.com/charleskfisher FOLLOW Jason: https://linktr.ee/calacanis Subscribe to our YouTube to watch all full episodes: https://www.youtube.com/channel/UCkkhmBWfS7pILYIk0izkc3A?sub_confirmation=1 FOUNDERS! Subscribe to the Founder University podcast: https://podcasts.apple.com/au/podcast/founder-university/id1648407190